Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy

Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.